key: cord-0811923-h631tx2r authors: Yu, Shinae; Song, Sae Am; Jun, Kyung Ran; Park, Ha Young; Lee, Jeong Nyeo title: Clinical Performance of Monocyte Distribution Width for Early Detection of Sepsis in Emergency Department Patients: A Prospective Study date: 2022-03-01 journal: Ann Lab Med DOI: 10.3343/alm.2022.42.2.286 sha: 4ed28107f74e6583f887ba56026d24cf920d1b9a doc_id: 811923 cord_uid: h631tx2r nan Dear Editor, Most patients with sepsis are admitted through the emergency department (ED), and their outcome is significantly worse if the diagnosis and treatment are delayed [1, 2] . Therefore, early de tection and treatment of sepsis are important in ED patients. Mo nocyte distribution width (MDW) is increased in patients with sepsis, making it a potential marker for the early diagnosis of sepsis [3, 4] . MDW is a measurable marker that can be obtained simultaneously with complete blood count (CBC). Thus, results can be obtained quickly, and additional blood collection from the patient for sepsis evaluation is not required. We evaluated the usefulness of MDW in predicting sepsis or septic shock us ing the Sepsis3 criteria in patients visiting the ED [5] . We enrolled 1,234 Korean patients aged > 18 years with a fe ver of ≥ 37.5°C and/or symptoms such as hypotension and men tal deterioration, whose initial evaluation included CBC and C reactive protein (CRP) tests on suspicion of infection, conducted within two hours of presenting to the ED at Haeundae Paik Hos pital, Busan, Korea, between May and August 2019. This study was approved by our Institutional Review Board (HPIRB 2018 12003), and the requirement for informed consent was waived because there is less than minimum risk to patients when using surplus samples. Samples for CBC, white blood cell (WBC) dif ferential count, and MDW were collected in K2EDTA tubes (Bec ton Dickinson, Plymouth, UK) and analyzed in a UniCel DxH 900 analyzer (Beckman Coulter, Inc., Brea, CA, USA). CRP and procalcitonin were measured from sera obtained by the centrif ugation of samples collected in VACUETTE ® CAT Serum Separa tor Clot Activators (Greiner BioOne GmbH, Kremsmünster, Aus tria) at 1,680 ×g for 10 minutes. CRP was analyzed using Hita chi 7600 instrument (Hitachi, Tokyo, Japan) and Nanopia CRP (Sekisui Medical Co., Ltd., Tokyo, Japan), and procalcitonin was analyzed using cobas e 411 analyzer (Roche Diagnostics GmbH, Mannheim, Germany) and Elecsys BRAHMS Procalcitonin (Ro che Diagnostics GmbH). All procedures were performed accord ing to the manufacturers' instructions. For statistical analyses, the chisquare test or Fisher's exact test was used for categori cal variables, and the Mann-Whitney U test or Kruskal-Wallis test was used for continuous variables. Receiver operating char acteristic (ROC) curve analysis was performed to assess the sen sitivity and specificity of MDW and blood count parameters to predict sepsis and septic shock. Optimal cutoffs for MDW and other laboratory markers were estimated using the classical You den index. All statistical analyses were carried out using SPSS version 24.0 (IBM Corp., Armonk, NY, USA), and P < 0.05 was considered statistically significant. All laboratory markers associated with sepsis, including MDW, were higher in patients with sepsis and septic shock than in those without sepsis (Table 1) . We confirmed hepatitis A in two of the 67 sepsis patients, both of whom had high MDW (28.65 and 29.32). Two of three fungal sepsis patients and both fungal sep tic shock patients, infected with Candida albicans or other yeast like fungus confirmed by culture from urine or respiratory sam ples, also had high MDW (26.52, 34.71, 33.94, and 37.25, re spectively). MDW increased significantly in COVID19 patients, especially in those hospitalized in the intensive care unit [6, 7] . MDW increases with progression from infection to sepsis and is the highest in sepsis patients with severe organ dysfunction [3] . This study demonstrated that MDW was the only biomarker that differed significantly between patients with sepsis and septic shock ( Table 1) . The area under the ROC curve of MDW was the highest (0.896, 95% confidence interval [CI]: 0.868-0.923), followed by that of CRP (0.894, 95% CI: 0.866-0.923), PCT (0.793, 95% CI: 0.742-0.844), and WBC count (0.692, 95% CI: 0.623-0.762). The statistically best cutoffs for predicting sepsis and septic shock were 31.750 mg/L for CRP, 0.099 µg/L for procalcitonin, 9.614 × 10 9 /L for WBC count, and 21.935 for MDW, the latter of which is higher than that (20.0) reported by Crouser, et al. [4] , similar to that (21.9) reported by Polilli, et al. [8] , and lower than that (23.5) reported by Agnello, et al. [9] . Wholeblood samples col lected in K2EDTA tubes reportedly yield lower MDW than those collected in K3EDTA tubes [9] . Therefore, the MDW cutoffs for samples collected in K2EDTA in those previous reports and our study were lower than those for samples in K3EDTA [4, 8, 9] . The highest sensitivity of 93.9% was achieved using 20 as the MDW cutoff. The highest specificity of 91.8% was achieved when the MDW cutoff of 21.935 was used in addition to a WBC cutoff of 9.614 × 10 9 /L. The specificities of CRP and procalcito nin increased when combined with the MDW results ( Table 2 ). In conclusion, MDW is a useful marker for sepsis screening in the ED because it shows high sensitivity when used as a sole marker and high specificity when combined with other markers. Therefore, MDW may be useful for early detection of sepsis, pre diction of sepsis severity, and effective clinical decision making, before other biomarkers or culture results and imaging interpre tations become available. None. Values are presented using frequencies (percentages) for categorical data and medians (interquartile range) for continuous data. *SIRS was confirmed if two or more criteria were present: temperature > 38°C or < 36°C, heart rate > 90/min, respiratory rate > 20/min or PaCO2 < 32 mmHg, WBC count > 12.00 × 10 9 /L or < 4.00 × 10 9 /L, or > 10% immature bands; † Infection was determined using clinical data from cultures and relevant imaging studies performed within two days of ED admission; ‡ Sepsis was defined as life threatening organ dysfunction identified by a total SOFA score of ≥ 2 points consequent to the infection, based on the Sepsis3 criteria [5] ; § Septic shock was defined as sepsis with hypotension re quiring vasopressors to maintain a mean arterial pressure of ≥ 65 mmHg and hyperlactatemia with serum lactate level of > 2 mmol/L despite adequate volume resuscitation; || P for comparison be tween no sepsis and sepsis plus septic shock; ¶ P for comparison between sepsis and septic shock. Abbreviations: SIRS, systemic inflammatory response syndrome; CRP, Creactive protein; WBC, white blood cell; MDW, monocyte distribution width; SOFA, sequential organ failure assessment. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline based performance improvement program Early diagnosis of sepsis in emergency departments, time to treat ment, and association with mortality: an observational study Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker Monocyte distribution width: a novel indicator of sepsis2 and sepsis3 in highrisk emergency department patients The third international consensus definitions for sepsis and septic shock (Sepsis3) The critical role of laboratory medicine during coronavirus disease 2019 (COVID19) and other viral outbreaks Table 2. Sensitivity and specificity of laboratory biomarkers for predicting sepsis and septic shock Laboratory biomarker Cut-off Sensitivity (95% CI) Specificity MDW plus WBC count MDW plus CRP MDW plus procalcitonin Elevated monocyte distribution width in COVID19 patients: the con tribution of the novel sepsis indicator Com parison of monocyte distribution width (MDW) and procalcitonin for early recognition of sepsis Monocyte distribution width (MDW) as a screening tool for sepsis in the emergency department All authors contributed to the study conception and design. Yu S, Song SA, Jun KR, and Park HY investigated and interpreted the results. Yu S, Song SA, and Jun KR curated and analyzed the data. Yu S wrote the first draft of the manuscript. Lee JN su pervised the study. All authors reviewed and edited the manu script and agreed to publish the final manuscript. None declared. The statistical analysis of this study received financial support from Inje University Haeundae Paik Hospital.